Respiratory events at the earliest phase of acute myeloid leukemia. Issue 11 (November 2014)

• Record Type: Journal Article
• Authors: Moreau, Anne-Sophie; Lengline, Etienne; Seguin, Amélie; Lemiale, Virginie; Canet, Emmanuel; Raffoux, Emmanuel; Schlemmer, Benoit; Azoulay, Elie
• Is Part Of: Leukemia & lymphoma. Volume 55:Issue 11(2014:Nov.)
• Page Start: 2556
• Page End: 2563
• Publication Date: 2014-11
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.3109/10428194.2014.887709
• Languages: English
• ISSNs: 1042-8194

Abstract

<abstract> <title>Abstract</title> <p>Acute myeloid leukemia (AML) can result in acute respiratory failure (ARF) during the first days, requiring intensive care unit (ICU) admission in half the cases. We describe three leukemia-specific syndromes responsible for ARF: leukostasis, pulmonary leukemic infiltration (PLI) and acute lysis pneumopathy (ALP). We retrospectively analyzed clinical and laboratory data from 114 patients admitted to a medical ICU within 10 days after a diagnosis of AML. Respiratory events (REs) occurred in 95 patients and were leukemia-specific in 58 patients (61%). Day-28 mortality was 34.5% in patients with leukemia-specific REs (leukostasis, 41%; PLI, 23%; and ALP, 31%) and 48.6% in patients with other REs. By multivariate analysis, independent risk factors for death were age &gt; 50 (odds ratio, 13; 95% confidence interval, 3–51), Eastern Cooperative Oncology Group (ECOG) status ≥ 2 (5.4; 1.8–17) and need for invasive mechanical ventilation (19; 5–75). Dexamethasone therapy was protective (0.26; 0.09–0.8), suggesting a role as a preventive treatment in patients with AML-related non-infectious pulmonary involvement.</p> </abstract>